<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>biosecurity on FinanClub</title>
    <link>https://finan.club/tags/biosecurity/</link>
    <description>Recent content in biosecurity on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sat, 12 Aug 2023 05:27:42 +0000</lastBuildDate><atom:link href="https://finan.club/tags/biosecurity/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>DNA</title>
      <link>https://finan.club/us/dna/</link>
      <pubDate>Sat, 12 Aug 2023 05:27:42 +0000</pubDate>
      
      <guid>https://finan.club/us/dna/</guid>
      <description>score:111
Chances: Ginkgo Bioworks&amp;rsquo; collaborations with industry leaders like Merck and Sumitomo Chemical highlight its potential for expanding its biomanufacturing capabilities and advancing synthetic biology. Participation in conferences and panels, such as the UBS MedTech, Tools and Genomics Summit, showcases Ginkgo&amp;rsquo;s position as a leading player in the field of cell programming and biosecurity.</description>
    </item>
    
  </channel>
</rss>
